Synlogic, Inc. (SYBX)

Synlogic, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Synlogic, Inc. (SYBX) is a Biotechnology company based in US with a market capitalization of $7.8M. Free cash flow was negative at -$4.4M. This page tracks SYBX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 1 employees · IPO Sep 30, 2015

Valuation

Valuation & price

$0.66as of May 17, 2026· -63.9% vs 52w high

P/E ratio

Latest-FY diluted EPS

0.66

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$1.81$1.19$0.56Jul 25Dec 25Jun 26
$0.5652-week range$1.83
Loading valuation history…

Fundamentals

Key fundamentals

$7.8M

Market cap

Revenue growth (YoY)

100.0%

Gross margin

-$4.4M

Free cash flow (USD)

-$14.7M

Net debt

Net cash position

0.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20162025

$444K$0

Free cash flow by year

20162025

-$26.5M-$4.4M

Gross margin by year

20212024

100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $0.05)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Quarterly reportMay 14, 2026Filing

    10-Q Filed

  • Annual reportApr 30, 2026Filing

    10-K Filed

Questions

Frequently asked questions

What is Synlogic, Inc.'s market cap?

Synlogic, Inc. (SYBX) has a market capitalization of $7.8M.

What is SYBX's P/E ratio?

A meaningful P/E ratio is not available for SYBX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SYBX's price-to-book (P/B) ratio?

SYBX trades at 0.66 times book value per share.

When did Synlogic, Inc. last report earnings?

SYBX last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying SYBX stock?

SEC Form 4 filings show no open-market insider buys at Synlogic, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.